Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04913337 |
|---|---|
| Brief Title: | Study of NGM707 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies |
| First Submitted : | May 20, 2021 |
| First Submitted that Met QC Criteria : | June 2, 2021 |
| First Posted : | June 4, 2021 |
| Last Update Submitted that Met QC Criteria : | February 8, 2023 |
| Last Update Posted : | February 10, 2023 |